Corrigendum to 'Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)'

Authors :: Rosa De Miguel
David Rial-Crestelo
Lourdes Dominguez-Dominguez
Rocío Montejano
Andrés Esteban-Cantos
Paula Aranguren-Rivas
Natalia Stella-Ascariz
Otilia Bisbal
Laura Bermejo-Plaza
Mónica Garcia-Alvarez
Belén Alejos
Asunción Hernando
Mireia Santacreu-Guerrero
Julen Cadiñanos
Mario Mayoral
Juan Miguel Castro
Victoria Moreno
Luz Martin-Carbonero
Rafael Delgado
Rafael Rubio
Federico Pulido
José Ramón Arribas
Source :: eBioMedicine
Publication Year :: 2023
Publisher :: Elsevier, 2023.

Subjects :: General Medicine
Corrigendum
General Biochemistry, Genetics and Molecular Biology

Tools